Publications by authors named "Carme Talarn"

Claim this Profile
5
5'-nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate-risk cytogenetics.
Johana Díaz-Santa, Rocío Rodríguez-Romanos, Rosa Coll, Gemma Osca, Marta Pratcorona, Carme Talarn

Eur J Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.
Jesus Fernandez-Sojo, Joan Cid, Carmen Azqueta, Elena Valdivia, Lluis Martorell, Carme Talarn

Bone Marrow Transplant· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis.
Rocío Parody, Isabel Sánchez-Ortega, Christelle Ferrá, Ramon Guardia, Carme Talarn

Oncol Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
José Luis Piñana, Rodrigo Martino, Irene García-García, Rocío Parody, María Dolores Morales, Carme Talarn

Exp Hematol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
Vicent Guillem, Marisa Calabuig, Salut Brunet, Jordi Esteve, Lourdes Escoda, Carme Talarn

Leuk Lymphoma· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation.
Miquel Granell, Alvaro Urbano-Ispizua, Aina Pons, Juan Ignacio Aróstegui, Bernat Gel, Carme Talarn

Blood· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anemia associated with impaired erythropoietin secretion after allogeneic stem cell transplantation: incidence, risk factors, and response to treatment.
Anna Gaya, Alvaro Urbano-Ispizua, Francesc Fernández-Avilés, Olga Salamero, Josep María Roncero, Carme Talarn

Biol Blood Marrow Transplant· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome.
Carme Talarn, Alvaro Urbano-Ispizua, Rodrigo Martino, José Antonio Pérez-Simón, Montserrat Batlle

Haematologica· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.
Miquel Granell, Alvaro Urbano-Ispizua, Juan Ignacio Aróstegui, Francesc Fernández-Avilés, Carmen Martínez, Carme Talarn

Haematologica· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases.
Francesc Fernández-Avilés, Alvaro Urbano-Ispizua, Marta Aymerich, Montserrat Rovira, Carmen Martínez, Carme Talarn

Exp Hematol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients.
Francisco Cervantes, Alberto Alvarez-Larrán, Carme Talarn, Marta Gómez, Emilio Montserrat

Br J Haematol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis